Header Logo

Connection

Lee Fairlie to Viral Vaccines

Back to Details
This is a "connection" page, showing publications Lee Fairlie has written about Viral Vaccines.
Lee Fairlie
Connection Strength
0,202
Viral Vaccines
  1. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Lancet HIV. 2022 05; 9(5):e309-e322.
    View in: PubMed
    Score: 0,202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.